Vanderbilt Ingram Cancer Center

Inhibition of BMP growth factor signaling reduces breast tumor burden and metastasis. Read More

Becker’s Hospital Review has named Vanderbilt University Medical Center among the “100 Hospitals and Health Systems With Great Oncology Programs.” Read More

Vanderbilt researchers have found that selenium deficiency may contribute to the racial disparity in lung cancer incidence. Read More

Two Vanderbilt-Ingram Cancer Center investigators have received multi-year breast cancer research grants from the Susan G. Komen for the Cure Breast Cancer Foundation. Read More

Charlie Haller had never smoked or used chewing tobacco and wasn’t a heavy drinker, so the 41-year-old Lyles, Tennessee, man wasn’t thinking about cancer when a mass developed on the side of his neck. Read More

A new study in East Asian women has identified three genetic changes linked to an increased risk of breast cancer. The research, led by Vanderbilt University investigators, was published online this week in Nature Genetics. Read More

The LUNGevity Foundation has awarded a 2014 Career Development Award for Translational Research to Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology. Read More

Vandana Abramson, M.D., assistant professor of Medicine and a breast cancer specialist at Vanderbilt-Ingram Cancer Center, has received the Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation (CCF). Read More

Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, has been named an at-large member of the National Cancer Policy Forum, an advisory group of the Institute of Medicine (IOM) of the National Academies. Read More

Tennessee-based congressional staff members spent the day on campus June 25 to learn firsthand about Vanderbilt services and resources. Read More

Vanderbilt continues to win recognition for its commitment to helping employees stay healthy, including support for activities that may protect against cancer. Vanderbilt University Medical Center (VUMC), in conjunction with Vanderbilt-Ingram Cancer Center (VICC), has been re-accredited as a CEO Cancer Gold Standard employer for 2014. In 2001, former President… Read More

New Vanderbilt research suggests patients with advanced melanoma — the most deadly form of skin cancer — could safely benefit from a combination of immunotherapy and targeted therapies aimed at specific gene mutations. Read More

My Cancer Genome, an online precision cancer medicine tool developed by researchers at Vanderbilt-Ingram Cancer Center, has unveiled an updated free mobile app that provides even more information about genetic alterations in various types of cancer and the therapies available to treat those alterations. Read More

Unique molecular "fingerprints" could explain the disparity in Wilms tumor incidence and point to novel, race-specific therapeutic targets. Read More

Using enhanced gene mutation testing to provide precision therapy for cancer patients was one of the themes at the annual Vanderbilt-Ingram Cancer Center (VICC) scientific retreat, held May 15 at the Vanderbilt Student Life Center. Read More

The contractile machinery inside tumor cells increases invasive properties, suggesting it might be a good target to inhibit cancer cell spread. Read More

Music will set the tone for Vanderbilt-Ingram Cancer Center’s annual Cancer Survivorship Celebration for patients, friends and families. Read More

A novel PET imaging probe detects tumor cell death in vivo and could be useful for personalizing cancer medicine. Read More

Sarah Rohde, M.D., assistant professor of Otolaryngology, examines Steve Corbitt for signs of head and neck cancer. Vanderbilt-Ingram Cancer Center and the Vanderbilt Department of Otolaryngology held the annual head and neck cancer screening event April 25. During the free and fast exams, physicians inspect the mouth… Read More

A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication. Read More